News
AGM statement - Intention to Seek Cancellation of Admission to AIM
18th June 2009
At the Annual General Meeting of international nanomaterials group Oxonica plc (LSE:OXN.L), to be held later today, Dr Kevin Matthews, Chief Executive Officer, will give the following update.
More »
Oxonica 2008 preliminary results released
24th March 2009
Oxonica plc (LSE: OXN.L), the leading international nanomaterials group, today announces preliminary
results for the year ended 31 December 2008.
More »
Appointment of non-executive director
5th January 2009
The Board of Oxonica plc ('Oxonica') confirms that it has appointed George Elliott, 56, as a
non-executive director of Oxonica.
More »
Oxonica wins Award for Innovation at the Thames Valley Business Awards 2008
21st November 2008
Oxonica plc ("Oxonica"), a leading international nanomaterials group, today announces that it has won the prestigious award for Innovation at the Thames Valley Business Awards held at the Berkshire Conference Centre in Reading.
More »
Assignment and Licence Agreement
19th September 2008
Oxonica plc (“Oxonica”), a leading international nanomaterials group, today announces that it has signed a strategic agreement relating to its Nanoplex™ technology with BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in New Jersey, USA.
More »